A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro)

被引:27
作者
Pekmezovic, Tatjana
Vukovic, Nada Suvajdzic
Kisic, Darija
Grgurevic, Anita
Bogdanovic, Andrija
Gotic, Mirjana
Bakrac, Milena
Brkic, Nenad
机构
[1] Univ Belgrade, Inst Epidemiol, Sch Med, Belgrade 11000, Serbia
[2] Inst Hematol, Clin Ctr Serbia, Belgrade 11000, Serbia
关键词
myelodysplastic syndrome; risk factors; epidemiology; case-control study; Belgrade;
D O I
10.1007/s00277-006-0128-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the study was to investigate factors related to the occurrence of myelodysplatic syndromes (MDS) in the population of Belgrade (Serbia Montenegro). The case-control study was conducted during the period 2000-2003. The study group consisted of 80 newly diagnosed MDS patients and 160 sex- and age-matched hospital controls with nonmalignant and noninfectious diseases. The disease categories in the control group were circulatory (51 patients, 32%), gastrointestinal (53 patients, 33%), and ophthalmological (56 patients, 35%) disorders. Conditional univariate and multivariate logistic regression analyses were applied. Multivariate analysis showed the following factors to be significantly related to MDS: exposure to chemicals (OR=10.8, 95%CI 3.2-36.2, p=0.0001), viral upper respiratory tract infections (twice a year or more, OR=5.8, 95%CI 2.5-13.6, p=0.0001), exposure to insecticides, pesticides and herbicides (OR=5.2, 95%CI 1.8-15.1, p=0.003), coffee (OR=5.1, 95%CI 1.9-13.7, p=0.001), and alcohol consumption (OR=2.2, 95%CI 1.1-4.6, p=0.033). The findings support the hypotheses that exposure to chemical agents, pesticides, insecticides, and herbicides, certain lifestyle factors (alcohol and coffee consumption), and frequent viral infections may be involved in the etiology of MDS, but these results should be confirmed by further investigations.
引用
收藏
页码:514 / 519
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 1996, Epidemiological research methods
[2]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[3]   Smoking and myelodysplastic syndromes [J].
Björk, J ;
Albin, M ;
Mauritzson, N ;
Strömberg, U ;
Johansson, B ;
Hagmar, L .
EPIDEMIOLOGY, 2000, 11 (03) :285-291
[4]   ALCOHOL-INDUCED BONE-MARROW DAMAGE - STATUS BEFORE AND AFTER A 4-WEEK PERIOD OF ABSTINENCE FROM ALCOHOL WITH OR WITHOUT DISULFIRAM - A RANDOMIZED BONE-MARROW STUDY IN ALCOHOL-DEPENDENT INDIVIDUALS [J].
CASAGRANDE, G ;
MICHOT, F .
BLUT, 1989, 59 (03) :231-236
[5]   Risk factors for myelodysplastic syndromes: a case-control study in Greece [J].
Dalamaga, M ;
Petridou, E ;
Cook, FE ;
Trichopoulos, D .
CANCER CAUSES & CONTROL, 2002, 13 (07) :603-608
[6]  
DATTA R, 1990, BLOOD, V76, P298
[7]   Autoimmune phenomena in patients with myelodysplastic syndromes [J].
Enright, H ;
Miller, W .
LEUKEMIA & LYMPHOMA, 1997, 24 (5-6) :483-489
[8]  
FARROW A, 1989, LEUKEMIA, V3, P33
[9]  
GOLDBERG H, 1990, CANCER RES, V50, P6876
[10]   A case-control study of myelodysplastic syndromes among Japanese men and women [J].
Ido, M ;
Nagata, C ;
Kawakami, N ;
Shimizu, H ;
Yoshida, Y ;
Nomura, T ;
Mizoguchi, H .
LEUKEMIA RESEARCH, 1996, 20 (09) :727-731